Hugues Pitre

Active Investor

Chief Executive Officer Southern Europe (France, Spain, Italy, Portugal) at Atida

Paris, Île-de-France

Hugues Pitre, Chief Executive Officer Southern Europe (France, Spain, Italy, Portugal) at Atida is an active investor based in Paris, Île-de-France. This profile covers what Hugues Pitre backs, at which stage, and how founders can reach out in 2026.

Mr. Hugues Pitre is an Angel Investor. Mr. Pitre served as Board Member at Diatly. The common thread in Hugues' career is the consumer. He started his career at Essilor where he spent 5 years in Portugal and Spain in marketing functions. Then he joined Bain & Company in Paris to do strategy consulting in the retail and mass consumption sectors. He then launched the Evian Affinity skincare brand, the fruit of a strategic alliance between Johnson & Johnson and the Danone Group, then in 2007 was appointed Managing Director Europe of Merisant, the world leader in sweeteners known for its Canderel and PureVia brands. Finally, Hugues extended his experience to digital by joining Amazon in 2014, the N ° 1 in E-commerce as Director of the Cultural Products division with under his responsibility the categories Books, Video Games, Video and Music as well as the pricing and customer experience for France. Hugues is a graduate of ESCP Europe and an MBA from INSEAD.

Investor type: Angel
Stages: Early Stage Venture
Invests in: Healthcare & BiotechDigital Health & HealthTechBiotech & PharmaMedTech & Medical DevicesSaaS & EnterpriseConsumer & RetailConsumer Goods (CPG)E-commerce & D2C
Location: Paris, Île-de-France
Typical check: $500K
Past investments: 6

Notable investments

AyolabJohnson & JohnsonEssilorMerisant CompanyAmazonDiatly

How to reach Hugues Pitre

Angels and operators like Hugues Pitre reply to specific, personalized notes that show real traction, not mass blasts. Build a verified list, write a note that fits their thesis, and track replies, all on Round Funded.

Frequently Asked Questions

What does Hugues Pitre invest in?

Hugues Pitre invests in Healthcare & Biotech, Digital Health & HealthTech, Biotech & Pharma and MedTech & Medical Devices, typically at Early Stage Venture. Match your sector and stage, then reach out with a personalized pitch.